J

Julie Jacobs

Argenx (Belgium)

ORCID: 0000-0003-2873-3364

64 papers and 2.3k citations.

PubIndex Score96Top 4% · mid-careerHow it's scored

64Publications

2.3kTotal Citations

First senior author: 2019

Top publicationsby citations

CD70: An emerging target in cancer immunotherapy

Julie Jacobs, Patrick Pauwels, Karen Zwaenepoel et al.|Pharmacology & Therapeutics|2015

Cited by 225

Indexing the rest of 64 publications…